1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. タイプ別スニペット
3.2. 専門分野別スニペット
3.3. サービス別スニペット
3.4. 用途別スニペット
3.5. エンドユーザー別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 慢性疾患の増加
4.1.2. 阻害要因
4.1.2.1. 機器に関連する高コスト
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. アンメット・ニーズ
5.6. PESTEL分析
5.7. 特許分析
5.8. SWOT分析
6. タイプ別
6.1. はじめに
6.1.1. 市場規模分析および前年比成長率分析（%）, タイプ別
6.1.2. 市場魅力度指数（タイプ別
6.2. 病院ベースのASC*市場
6.2.1. はじめに
6.2.2. 市場規模分析と前年比成長率分析(%)
6.3. フリースタンディングASC
7. 専門分野別
7.1. はじめに
7.1.1. 市場規模分析および前年比成長率分析（%）, 専門分野別
7.1.2. 市場魅力度指数（スペシャリティ別
7.2. 単一スペシャリティASC
7.2.1. はじめに
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. マルチスペシャリティASC
8. サービス別
8.1. はじめに
8.1.1. サービス別市場規模分析および前年比成長率分析(%)
8.1.2. 市場魅力度指数（サービス別
8.2. 診断薬
8.2.1. はじめに
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 治療
9. 用途別
9.1. 導入
9.1.1. 市場規模分析および前年比成長率分析（%）, アプリケーション別
9.1.2. 市場魅力度指数（用途別
9.2. 消化器*領域
9.2.1. はじめに
9.2.2. 市場規模分析と前年比成長率分析(%)
9.3. 眼科
9.4. 整形外科
9.5. 神経学
9.6. 皮膚科
9.7. 泌尿器科
9.8. その他
10. エンドユーザー別
10.1. はじめに
10.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
10.1.2. 市場魅力度指数、エンドユーザー別
10.2. 病院*市場
10.2.1. はじめに
10.2.2. 市場規模分析と前年比成長率分析(%)
10.3. 専門クリニック
10.4. その他
11. 競争環境
11.1. 競争シナリオ
11.2. 市場ポジショニング／シェア分析
11.3. M&A分析
12. 企業プロフィール
12.1. SCA Health*
12.1.1. 会社概要
12.1.2. 製品ポートフォリオと内容
12.1.3. 財務概要
12.1.4. 主な展開
12.2. Amsurg
12.3. HCA Management Services L.P
12.4. Fujifilm Holdings
12.5. Medtronic
12.6. Stryker
12.7. Koninklijke Philips N.V
12.8. Siemens Healthcare Private Limited
12.9. Boston Scientific Corporation
12.10. Johnson & Johnson Services Inc. （※リストは除外）
13. 付録
13.1. ジョンソン・エンド・ジョンソンについて
13.2. お問い合わせ
The Asia Pacific ambulatory surgical centers market reached US$ 18,500 million in 2023 and is expected to reach US$ 30,492 million by 2031, growing at a CAGR of 6.6% during the forecast period 2024-2031.
Ambulatory surgical centers (ASCs) are specialized healthcare facilities that offer outpatient surgical services so that patients can get treatments done without needing to stay overnight in the hospital. These facilities specialize in carrying out a wide range of surgical procedures, including gastrointestinal treatments as well as orthopedic and ophthalmology surgery. Because they provide more individualized patient care, shorter wait times, and costs that are frequently 20% to 50% less than in typical hospital settings, ASCs are gaining popularity these days.
Patients gain from a more comfortable environment and a more efficient procedure, which usually leads to quicker recovery periods and lower infection rates.
The ASC operational model places a strong emphasis on specialization and efficiency because their staff members are highly qualified professionals committed to providing outpatient care.
Market Dynamics: Drivers
Increasing prevalence of chronic diseases
The rising prevalence of chronic diseases propels the market growth. For instance, according to the National Institute of Health, noncommunicable diseases commonly include cardiovascular disease (CVD), various cancers, chronic respiratory illnesses, diabetes, and so on which are estimated to account for around 60% of all deaths. CVDs such as ischaemic heart disease and cerebrovascular such as stroke account for 17.7 million deaths and are the leading cause.
In accordance with the World Health Organization, India accounts for one-fifth of these deaths worldwide especially in younger population. The results of the Global Burden of Disease study state an age-standardized CVD death rate of 272 per 100000 population in India which is much higher than the global average of 235. CVDs strike Indians a decade earlier than the Western population.
In Indians, one of every ten persons aged 18 years has an increased blood glucose level. There were more than 73 million cases of diabetes in India in 2017 which is the highest in any country across the globe. Diabetes has become a challenge in India with a prevalence of 8.8% in the age group of 20 and 70 years. The rising prevalence of diabetes and other noncommunicable diseases has been linked to rapid urbanization, and globalization coupled with increasing sedentary lifestyles, unhealthy diets, overweight and obesity, tobacco use, and increasing life expectancy.
Restraints
Factors such as high costs of infrastructure and deployment are expected to hamper the market. For many healthcare providers, setting up and sustaining an ASC can be too costly both initially and over time. Significant recurring expenditures are associated with operating an ASC, including pay for IT workers who oversee the facility, maintenance, and repair charges, and electricity bills for cooling systems and servers.
Market Segment Analysis
The Asia Pacific ambulatory surgical centers market is segmented based on type, specialty, service, application, and end-user.
The segment hospital-based ASCs accounted for approximately 42.1% of the Asia Pacific ambulatory surgical centers market share.
The hospital-based ASCs segment is expected to hold the largest market share over the forecast period. In this segment, technological advancements would drive this market. Hospital-based ambulatory surgery centers are specialized establishments that offer outpatient surgical treatments, enabling patients to receive treatment without having to stay overnight in the hospital. Hospital-based ASCs function as distinct organizations with a focus on outpatient surgery even if they are integrated inside hospitals.
In response to the rising demand for same-day surgical treatments, they seek to offer a more effective and patient-centered approach to surgical care. Procedures at ASCs are usually less expensive than in conventional hospital settings. Because ASCs have lower overhead costs, patients can save anywhere from 20% to 50% on their surgery charges. Both patients and healthcare systems benefit from this financial efficiency.
Market Segmentation
By Type
Hospital-based ASCs
Free Standing ASCs
By Specialty
Single Specialty ASC
Multispecialty ASC
By Service
Diagnostics
Treatment
By Application
Gastroenterology
Ophthalmology
Orthopedics
Neurology
Dermatology
Urology
Others
By End-User
Hospitals
Specialty Clinics
Others
Market
Competitive Landscape
The major players in the Asia Pacific ambulatory surgical centers market include SCA Health, Amsurg, HCA Management Services L.P, Fujifilm Holdings, Medtronic, Stryker, Koninklijke Philips N.V, Siemens Healthcare Private Limited, Boston Scientific Corporation, Johnson & Johnson Services Inc. among others.
Key Developments
In September 2023, Philips launched a new image-guided therapy mobile C-arm system called Zenition 30. The Zenition 30 system is equipped with advanced imaging AI algorithms that offer surgeons greater flexibility, control, and personalization in C-arm operation and image acquisition and reduce dependency on technician support for a wide variety of minimally invasive procedures.,
Why Purchase the Report?
To visualize the Asia Pacific ambulatory surgical centers
Market Segmentation based on type, specialty, service, application, and end-user as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of Asia Pacific ambulatory surgical centers market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.
The Asia Pacific ambulatory surgical centers market report would provide approximately 51 tables, 54 figures, and 181 Pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Specialty
3.3. Snippet by Service
3.4. Snippet by Application
3.5. Snippet by End-User
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Prevalence of Chronic Diseases
4.1.2. Restraints
4.1.2.1. High Cost Associated with the Equipment
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. By Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Hospital-based ASCs*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Free Standing ASCs
7. By Specialty
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specialty
7.1.2. Market Attractiveness Index, By Specialty
7.2. Single Specialty ASC*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Multispecialty ASC
8. By Service
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
8.1.2. Market Attractiveness Index, By Service
8.2. Diagnostics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Treatment
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Gastroenterology*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ophthalmology
9.4. Orthopedics
9.5. Neurology
9.6. Dermatology
9.7. Urology
9.8. Others
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Specialty Clinics
10.4. Others
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. SCA Health*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Amsurg
12.3. HCA Management Services L.P
12.4. Fujifilm Holdings
12.5. Medtronic
12.6. Stryker
12.7. Koninklijke Philips N.V
12.8. Siemens Healthcare Private Limited
12.9. Boston Scientific Corporation
12.10. Johnson & Johnson Services Inc. (*LIST NOT EXHAUSTIVE)
13. Appendix
13.1. About Us and Services
13.2. Contact Us
*** 外来手術センターの世界市場に関するよくある質問(FAQ) ***
・外来手術センターの世界市場規模は？
→DataM Intelligence社は2023年の外来手術センターの世界市場規模を185億米ドルと推定しています。
・外来手術センターの世界市場予測は？
→DataM Intelligence社は2031年の外来手術センターの世界市場規模を304億9200万米ドルと予測しています。
・外来手術センター市場の成長率は？
→DataM Intelligence社は外来手術センターの世界市場が2024年～2031年に年平均6.6%成長すると展望しています。
・世界の外来手術センター市場における主要プレイヤーは？
→「SCA Health, Amsurg, HCA Management Services L.P, Fujifilm Holdings, Medtronic, Stryker, Koninklijke Philips N.V, Siemens Healthcare Private Limited, Boston Scientific Corporation, Johnson & Johnson Services Inc. など ...」を外来手術センター市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
